M. Rock

发表

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

M. Kosorok, P. Farrell, J. Collins, 2005, JAMA.

Psychosocial Risk Associated With Newborn Screening for Cystic Fibrosis: Parents’ Experience While Awaiting the Sweat-Test Appointment

R. Koscik, P. Farrell, A. Tluczek, 2005, Pediatrics.

Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa.

J. Moss, P. Farrell, J. Barbieri, 2002, The Journal of infectious diseases.

Cystic fibrosis and CRMS screening: what the primary care pediatrician should know.

M. Rock, Jack K. Sharp, 2010, Pediatric annals.

Cystic fibrosis , are we missing in India ?

M. Kosorok, R. Laessig, M. Rock, 2012 .

Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond.

M. Rosenfeld, R. Parad, F. Accurso, 2009, The Journal of pediatrics.

Impact of Intermediate Cystic Fibrosis Classification on Parents’ Perceptions of Child Vulnerability and Protectiveness

Roger L. Brown, A. Tluczek, M. Rock, 2019, Journal of family nursing.

Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis.

M. Kosorok, L. S. Broderick, P. Farrell, 2009, Radiology.

Changing incidence of cystic fibrosis in Wisconsin, USA

P. Simpson, M. Nugent, M. Rock, 2015, Pediatric pulmonology.

Diagnosis of Cystic Fibrosis in Screened Populations

D. Sanders, M. Rosenfeld, H. Blau, 2017, The Journal of pediatrics.

Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition.

M. Kosorok, R. Koscik, P. Farrell, 2004, Pediatrics.

Aerosol delivery and safety of recombinant human deoxyribonuclease in young children with cystic fibrosis: a bronchoscopic study. Pulmozyme Pediatric Broncoscopy Study Group.

R. Ahrens, M. Rock, J. Wagener, 1998, The Journal of pediatrics.

The Sensitivity of Lung Disease Surrogates in Detecting Chest CT Abnormalities in Children With Cystic Fibrosis

D. Sanders, P. Farrell, Zhanhai Li, 2012, Pediatric pulmonology.

Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis.

M. Kosorok, P. Farrell, J. Collins, 2003, American journal of respiratory and critical care medicine.

Oxandrolone Improves Height Velocity and BMI in Patients with Cystic Fibrosis

M. Rock, E. Connor, D. Allen, 2010, International journal of pediatric endocrinology.

Defining and identifying early‐onset lung disease in cystic fibrosis with cumulative clinical characteristics

P. Farrell, M. Rock, J. Gaffin, 2022, Pediatric pulmonology.

Use of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy

M. Rock, E. Truemper, C. L'Hommedieu, 1986, Critical care medicine.

Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition

M. Kosorok, P. Farrell, J. Collins, 2001, Pediatric pulmonology.

A. Grieve, T. Becker, P. Farrell, 2013, Journal of developmental and behavioral pediatrics : JDBP.

Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development. Proceedings of a 1997 workshop.

M. Kosorok, R. Laessig, P. Farrell, 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Growth and pulmonary outcomes during the first 2 y of life of breastfed and formula-fed infants diagnosed with cystic fibrosis through the Wisconsin Routine Newborn Screening Program.

P. Farrell, S. Shoff, M. Rock, 2011, The American journal of clinical nutrition.

Newborn screening for cystic fibrosis.

M. Rock, 1991, Clinics in chest medicine.

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies.

D. Sanders, P. Farrell, M. Rock, 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Clarification of Laboratory and Clinical Variables That Influence Cystic Fibrosis Newborn Screening With Initial Analysis of Immunoreactive Trypsinogen

P. Farrell, W. Gershan, Zhanhai Li, 2009, Pediatrics.

Optimal DNA tier for the IRT/DNA algorithm determined by CFTR mutation results over 14 years of newborn screening.

P. Farrell, M. Rock, H. Levy, 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Regional differences in the evolution of lung disease in children with cystic fibrosis

D. Sanders, P. Farrell, J. Collins, 2012, Pediatric pulmonology.

Early diagnosis of cystic fibrosis in the newborn period and risk of Pseudomonas aeruginosa acquisition in the first 10 years of life: A registry-based longitudinal study.

M. Khoury, M. Gwinn, S. Fitzsimmons, 2001, Pediatrics.

Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis.

M. Kosorok, P. Farrell, E. Mischler, 1997, Pediatrics.

Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!

M. Kosorok, R. Laessig, P. Farrell, 2005, The Journal of pediatrics.

Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening.

M. Kosorok, R. Koscik, P. Farrell, 2005, The Journal of pediatrics.

Effects of an Antioxidant‐enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial

J. Clancy, K. McCoy, D. Orenstein, 2018, American journal of respiratory and critical care medicine.

Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: Assessment of clinic exposures and microbial genotypes

P. Farrell, S. E. West, Zhanhai Li, 2010, Pediatric pulmonology.

Newborn Screening for Cystic Fibrosis

M. Rock, Jack K. Sharp, 2008, Clinical reviews in allergy & immunology.

F1099L-CFTR (c.3297C>G) has Impaired Channel Function and Associates with Mild Disease Phenotypes in Two Pediatric Patients

S. Srinivasan, M. Rock, Yanhui H Zhang, 2021, Life.

Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

M. Kosorok, R. Laessig, P. Farrell, 2001, Pediatrics.

The diagnostic utility of bronchoalveolar lavage in immunocompetent children with unexplained infiltrates on chest radiograph.

M. Rock, 1995, Pediatrics.

Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

Vicky A Legrys, G. Cutting, C. Castellani, 2008, The Journal of pediatrics.

Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation

Margaret Rosenfeld, Frank Accurso, Philip M. Farrell, 2017, The Journal of pediatrics.

Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.

M. Kosorok, P. Farrell, S. E. West, 2002, JAMA.

TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study.

S. Bull, A. Davis, J. Wunder, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Impact of the CFTR Gene Discovery on Cystic Fibrosis Diagnosis, Counseling, and Preventive Therapy

P. Farrell, M. Rock, M. Baker, 2020, Genes.

Early Immune Response to the Components of the Type III System of Pseudomonas aeruginosa in Children with Cystic Fibrosis

M. Kosorok, J. Moss, P. Farrell, 2005, Journal of Clinical Microbiology.

Newborn Screening for Cystic Fibrosis: Parents’ Preferences Regarding Counseling At the Time of Infants’ Sweat Test

R. Koscik, P. Farrell, A. Tluczek, 2006, Journal of Genetic Counseling.

How to define CRMS/CFSPID conversion to CF

M. Rock, 2020, Pediatric Pulmonology.

Refinement of newborn screening for cystic fibrosis with next generation sequencing

P. Farrell, M. Rock, M. Baker, 2022, Pediatric pulmonology.

MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study.

P. D. Lee, S. Bull, A. Davis, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MDR1 Gene E xpression a nd O utcome i n O steosarcoma: A Prospective, M ulticenter S tudy

S. Bull, A. Davis, J. Wunder, 2000 .

Immunoreactive trypsinogen screening for cystic fibrosis: Characterization of infants with a false‐positive screening test

R. Laessig, P. Farrell, E. Mischler, 1989, Pediatric pulmonology.

Long-term follow-up of cystic fibrosis newborn screening: psychosocial functioning of adolescents and young adults.

Roger L. Brown, A. Grieve, P. Farrell, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Relationships among health-related quality of life, pulmonary health, and newborn screening for cystic fibrosis.

A. Grieve, P. Farrell, A. Tluczek, 2011, Chest.

Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis

P. Farrell, A. Laxova, M. Rock, 1998, Pediatric pulmonology.

Computed tomography in the evaluation of cystic fibrosis lung disease.

W. Huda, M. McNitt-Gray, R. Castile, 2005, American journal of respiratory and critical care medicine.

Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis

P. Farrell, J. Collins, Zhanhai Li, 2003, Pediatric pulmonology.

A new method of sweat testing: the CF Quantum®sweat test.

Jens Eickhoff, J. Eickhoff, M. Rock, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Neonatal screening for cystic fibrosis in Wisconsin.

R. Laessig, P. Farrell, E. Mischler, 1989, Wisconsin Medical Journal.

A family study describing second cousins with cystic fibrosis and no common ancestor who is a carrier.

V. Park, M. Rock, M. Smith, 1995, Journal of medical genetics.

Newborn screening alone insufficient to improve pulmonary outcomes for cystic fibrosis.

Ryan J Coller, J. Eickhoff, P. Farrell, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels.

R. Laessig, P. Farrell, E. Mischler, 1990, Pediatrics.

Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.

R. Laessig, P. Farrell, M. Rock, 2005, The Journal of pediatrics.

Newborn Screening for Cystic Fibrosis Is Complicated by Age-Related Decline in Immunoreactive Trypsinogen Levels

Lee-Jen Wei, R. Laessig, P. Farrell, 1990, Pediatrics.

A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency

R. Stern, G. Dopico, D. Orenstein, 2000, American Journal of Gastroenterology.

Risk factors for the progression of cystic fibrosis lung disease throughout childhood.

D. Sanders, C. Férec, P. Farrell, 2014, Annals of the American Thoracic Society.

Refining the continuum of CFTR‐associated disorders in the era of newborn screening

S. McColley, P. Farrell, M. Nugent, 2016, Clinical genetics.

Quality of life of children with cystic fibrosis.

J. Douglas, R. Koscik, P. Farrell, 2005, The Journal of pediatrics.

Chapter 59 – Neonatal Screening for Cystic Fibrosis

P. Farrell, M. Rock, 2006 .

Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

G. Cutting, C. Castellani, R. Parad, 2008, The Journal of pediatrics.

A new method of sweat testing: the CF Quantum®sweat test.

J. Eickhoff, M. Rock, Linda M. Makholm, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

M. Rosenfeld, R. Parad, F. Accurso, 2009, The Journal of pediatrics.

Effect on Airway Resistance of Ketamine by Aerosol In Guinea Pigs

Michael F. Wilson, M. Lerner, D. Brackett, 1989, Anesthesia and analgesia.